Online:
Visits:
Stories:
Profile image
By Data Bridge Market Research
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Cancer Biomarkers Market Forecast to 2022

Friday, February 10, 2017 10:19
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The global cancer biomarkers market has accounted to USD 9.7 billion in 2015, growing at a CAGR of 12.2% from 2016 to 2022, and is expected to reach USD 21.8 billion by 2022.

Global Cancer Biomarkers Market, By Tumor (Breast, Lung, Prostate), By Type (Protein Biomarker, Genetic Biomarkers), By Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), By Application (Diagnostic, Drug Discovery, Prognostic), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022

Read More: Global Cancer Biomarkers Markets Report by Tumour Type

The market is segmented based on tumor, type, profiling technology, application, and geography.

By Tumour:

·         Breast

·         Lung

·         Prostate

By Type:

·         Protein Biomarker

·         Genetic Biomarkers

By Profiling Technology:

·         Proteomics

·         Genomics

·         Imaging

·         Immunoassay

By Application:

·         Diagnostic

·         Drug Discovery

·         Prognostic

 

Based on geographical segmentation the cancer biomarkers market is segmented into 5 regions such as North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares covers major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.

Key Players operating in the Global Cancer Biomarkers Market:

·         Abbott Laboratories

·         DiagnoCure Inc.

·         Affymetrix, Inc.

·         Illumina, Inc.

·         Qiagen N.V.

·         Roche Diagnostics Ltd.

·         Agilent Technologies Inc.

·         Quest Diagnostics Inc.

·         Merck & Co. Inc.

·         Hologic, Inc.

·         Becton Dickinson and Company

Browse Full Report

Related Reports:

Global Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography (North America, Europe, Asia Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024

Access to The Above Report

Contact:

Data Bridge Market Research

Office Number-317, Amanora Chambers,

Magarpatta Road, Hadapsar,

Pune -411028

Contact via Email: 

Visit Data Bridge Blog

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.